These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9230743)

  • 21. [New pharmacological approaches: rhDNase].
    Tournier G; Sardet A; Grosskopf C; Baculard A; Delaisi B
    Rev Pneumol Clin; 1995; 51(3):193-200. PubMed ID: 7569583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term recombinant human DNase in bronchiectasis. Effect on clinical state and in vitro sputum transportability.
    Wills PJ; Wodehouse T; Corkery K; Mallon K; Wilson R; Cole PJ
    Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):413-7. PubMed ID: 8756815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis.
    Ramsey BW; Astley SJ; Aitken ML; Burke W; Colin AA; Dorkin HL; Eisenberg JD; Gibson RL; Harwood IR; Schidlow DV
    Am Rev Respir Dis; 1993 Jul; 148(1):145-51. PubMed ID: 8317790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy.
    App EM; King M; Helfesrieder R; Köhler D; Matthys H
    Am Rev Respir Dis; 1990 Mar; 141(3):605-12. PubMed ID: 2310093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aerosolized dornase alpha (rhDNase) in cystic fibrosis.
    Bates RD; Nahata MC
    J Clin Pharm Ther; 1995 Dec; 20(6):313-5. PubMed ID: 8847368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is cystic fibrosis mucus abnormal?
    King M
    Pediatr Res; 1981 Feb; 15(2):120-2. PubMed ID: 7254936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis.
    Ranasinha C; Assoufi B; Shak S; Christiansen D; Fuchs H; Empey D; Geddes D; Hodson M
    Lancet; 1993 Jul; 342(8865):199-202. PubMed ID: 8100928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compaction assay: a rapid and simple in vitro method to assess the responsiveness of a biopolymer matrix to enzymatic modification.
    Daugherty AL; Patapoff TW; Clark RC; Sinicropi DV; Mrsny RJ
    Biomaterials; 1995 May; 16(7):553-8. PubMed ID: 7492720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medium term treatment of stable stage cystic fibrosis with recombinant human DNase I.
    Shah PL; Scott SF; Fuchs HJ; Geddes DM; Hodson ME
    Thorax; 1995 Apr; 50(4):333-8. PubMed ID: 7785003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New treatment strategies in cystic fibrosis: rhDNase.
    Shah PL; Hodson ME
    Monaldi Arch Chest Dis; 1996 Apr; 51(2):125-9. PubMed ID: 8680379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective review of the effects of rhDNase in children with cystic fibrosis.
    Davies J; Trindade MT; Wallis C; Rosenthal M; Crawford O; Bush A
    Pediatr Pulmonol; 1997 Apr; 23(4):243-8. PubMed ID: 9141109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant human DNase in management of lobar atelectasis due to retained secretions.
    Touleimat BA; Conoscenti CS; Fine JM
    Thorax; 1995 Dec; 50(12):1319-21; discussion 1323. PubMed ID: 8553310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [rhDNase: scientific background, cloning and production].
    Shak S
    Arch Pediatr; 1995 Jul; 2(7):666-9. PubMed ID: 7663657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amiloride inhalation therapy in cystic fibrosis. Influence on ion content, hydration, and rheology of sputum.
    Tomkiewicz RP; App EM; Zayas JG; Ramirez O; Church N; Boucher RC; Knowles MR; King M
    Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1002-7. PubMed ID: 8214916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of nebulised recombinant DNase on neutrophil elastase load in cystic fibrosis.
    Costello CM; O'Connor CM; Finlay GA; Shiels P; FitzGerald MX; Hayes JP
    Thorax; 1996 Jun; 51(6):619-23. PubMed ID: 8693445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical studies of rhDNase in moderately and severely affected patients with cystic fibrosis--an overview.
    Hodson ME
    Respiration; 1995; 62 Suppl 1():29-32. PubMed ID: 7792438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhaled hypertonic saline increases sputum expectoration in cystic fibrosis.
    Riedler J; Reade T; Button B; Robertson CF
    J Paediatr Child Health; 1996 Feb; 32(1):48-50. PubMed ID: 8652214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of rhDNase on purulent airway secretions in chronic bronchitis.
    Puchelle E; Zahm JM; de Bentzmann S; Grosskopf C; Shak S; Mougel D; Polu JM
    Eur Respir J; 1996 Apr; 9(4):765-9. PubMed ID: 8726943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA concentration and length in sputum of patients with cystic fibrosis during inhalation with recombinant human DNase.
    Brandt T; Breitenstein S; von der Hardt H; Tümmler B
    Thorax; 1995 Aug; 50(8):880-2. PubMed ID: 7570441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of mucous glycoproteins in the rheologic properties of cystic fibrosis sputum.
    Lethem MI; James SL; Marriott C
    Am Rev Respir Dis; 1990 Nov; 142(5):1053-8. PubMed ID: 2240828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.